Cargando…

36. Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19

BACKGROUND: Little is known about risk factors for readmission after COVID-19 hospitalizations. Knowledge of these factors may help to identify patients at increased risk and may help to prevent these rehospitalizations. METHODS: This historical cohort study was conducted at a tertiary care academic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Elisa Akagi, Santos, Claudia Villatoro, Sharma, Mamta, Szpunar, Susan M, Saravolatz, Louis, Bhargava, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Oral Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644548/ http://dx.doi.org/10.1093/ofid/ofab466.036

Ejemplares similares

Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18–65 years
por: Bhargava, Ashish, et al.
Publicado: (2020)

Clinical features and risk factors for community-onset bloodstream infections among coronavirus disease 2019 (COVID-19) patients
por: Akagi, Elisa F., et al.
Publicado: (2021)

511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19
por: Bhargava, Ashish, et al.
Publicado: (2023)

High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
por: Bhargava, Ashish, et al.
Publicado: (2021)

314. Six-Month Post-Acute Sequelae of COVID-19: High Self-Reported Morbidity among Women and Younger Adults
por: Bhargava, Ashish, et al.
Publicado: (2021)

Risk Factors for In-Hospital Mortality from COVID-19 Among Nursing Home Patients—An Urban Center Experience
por: Vahia, Amit, et al.
Publicado: (2021)

Six-Month Post-Acute COVID-19: High Self-Reported Morbidity Among Adults Younger Than Sixty Years and Females
por: Bhargava, Ashish, et al.
Publicado: (2021)

Clinical Features and Risk Factors for In-Hospital Mortality From COVID-19 Infection at a Tertiary Care Medical Center, at the Onset of the US COVID-19 Pandemic
por: Bhargava, Ashish, et al.
Publicado: (2021)

Do risk factors at the time of hospital admission differ by sex for in-hospital mortality from coronavirus disease 2019 (COVID-19)?
por: Sharma, Mamta, et al.
Publicado: (2021)

1464. The Clinical Features of Pneumonia Caused by Legionella pneumophila vs. Streptococcus pneumoniae: A Retrospective Study
por: Salahie, Sima, et al.
Publicado: (2018)

636. Epidemiology and Outcome Among the Elderly Hospitalized Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

2611. Risk Factors Associated with Longer Hospital Stay in Adult Patients with Respiratory Syncytial Virus Infections
por: Bhargava, Ashish, et al.
Publicado: (2023)

635. Morbidity and Mortality Associated with Respiratory Syncytial Virus Infections Among the Adult Hospitalized Patients
por: Bhargava, Ashish, et al.
Publicado: (2023)

Association of Insomnia with 30-Day Postpartum Readmission: A Retrospective Analysis
por: Kendle, Anthony M., et al.
Publicado: (2023)

1600 Lower lipid screening rates among HIV positive outpatients in an urban clinic
por: Simeunovic, Gordana, et al.
Publicado: (2014)

The GeriPACT Initiative to Prevent All-Cause 30-Day Readmission in High Risk Elderly
por: Powers, James S., et al.
Publicado: (2021)

High Mortality among 30-Day Readmission after Stroke: Predictors and Etiologies of Readmission
por: Nouh, Amre M., et al.
Publicado: (2017)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
por: Yang, Sara, et al.
Publicado: (2022)

Unplanned 30-day readmission rates in patients undergoing endo-urological surgeries for upper urinary tract calculi
por: Kumar, Manoj, et al.
Publicado: (2018)

Multicenter study of risk factors of unplanned 30‐day readmissions in pediatric oncology
por: Hoenk, Kamila, et al.
Publicado: (2021)

62. Factors Associated with 30-Day ED Readmission Following Initial ED Discharge for Suspected Sepsis
por: Moscowitz, Anna E, et al.
Publicado: (2020)

Impact of traditional versus nontraditional initiation dosing schedule of paliperidone palmitate on 30-day readmission and safety
por: Kim, Erika, et al.
Publicado: (2023)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
por: Lau, Christine SM, et al.
Publicado: (2017)

“Weekend Effect” on 30-Day Readmissions among Stroke Survivors: An Analysis of the National Readmission Database
por: Khaksari, Bijan J., et al.
Publicado: (2019)

Examining 30-day COPD readmissions through the emergency department
por: Rezaee, Michael E, et al.
Publicado: (2017)

Paracentesis in cirrhotics is associated with increased risk of 30-day readmission
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

The Impact of Ischaemic Stroke Subtype on 30-day Hospital Readmissions
por: Bjerkreim, Anna Therese, et al.
Publicado: (2018)

Patient vs provider perspectives of 30-day hospital readmissions
por: Smeraglio, Andrea, et al.
Publicado: (2019)

The relationship between diabetes mellitus and 30-day readmission rates
por: Ostling, Stephanie, et al.
Publicado: (2017)

Medication adherence as a predictor of 30-day hospital readmissions
por: Rosen, Olga Z, et al.
Publicado: (2017)

Avoidable 30‐day readmissions in patients undergoing vascular surgery
por: Knighton, A., et al.
Publicado: (2019)

187. The 30-Day Readmission and 30-Day Mortality of Hemodialysis Patients with Antibiotic-Resistant Gram-Negative Bacteremia
por: Oommen, Jomi K, et al.
Publicado: (2019)

Training Internal Medicine Residents to Provide Care and Treatment for Human Immunodeficiency Virus-1-Infected Patients
por: Valenti, Sharon, et al.
Publicado: (2019)

Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes
por: Spanakis, Elias K, et al.
Publicado: (2020)

Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission
por: Dundon, John, et al.
Publicado: (2023)

B‐Type Natriuretic Peptide Predicts 30‐Day Readmission for Heart Failure but not Readmission for Other Causes
por: Flint, Kelsey M., et al.
Publicado: (2014)

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale
por: Chamberlain, Ronald S, et al.
Publicado: (2018)

Sex‐Based Differences in 30‐Day Readmissions After Cardiac Arrest: Analysis of the Nationwide Readmissions Database
por: Sobti, Navjot Kaur, et al.
Publicado: (2022)

Readmissions in the Emergency Department
por: Mouridsen, Mads Strunk, et al.
Publicado: (2012)

535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19
por: MALIK, I S M A I L O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_av0tvos5g2kbbbbvm8n32oapjd